Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence trial of generic fluticasone propionate + salmeterol versus Advair Diskus in asthma
2018-002631-15Phase 3Completed
- Sponsor
- Respirent Pharmaceuticals Co. Ltd.
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in asthma comparing Test generic fluticasone propionate + salmeterol, Active comparator Advair Diskus and Placebo (3 arms). Primary endpoint: Area under the serial FEV1-time curve from 0 to 12 hours on day 1. Started Jul 2018; status: completed.
02
Drugs
salmeterol + fluticasonefluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2018-002631-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002631-15.